Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Notes Payables: 2009-2012

Historic Notes Payables for Ani Pharmaceuticals (ANIP) over the last 3 years, with Dec 2012 value amounting to $4.1 million.

  • Ani Pharmaceuticals' Notes Payables was N/A to $4.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $4.1 million, marking a year-over-year change of. This contributed to the annual value of $4.1 million for FY2012, which is N/A change from last year.
  • As of FY2012, Ani Pharmaceuticals' Notes Payables stood at $4.1 million, which was up 265.84% from $1.1 million recorded in FY2010.
  • Over the past 5 years, Ani Pharmaceuticals' Notes Payables peaked at $16.7 million during FY2009, and registered a low of $1.1 million during FY2010.
  • Over the past 2 years, Ani Pharmaceuticals' median Notes Payables value was $2.6 million (recorded in 2010), while the average stood at $2.6 million.
  • Data for Ani Pharmaceuticals' Notes Payables shows a maximum YoY slumped of 93.34% (in 2010) over the last 5 years.
  • Over the past 3 years, Ani Pharmaceuticals' Notes Payables (Yearly) stood at $16.7 million in 2009, then slumped by 93.34% to $1.1 million in 2010, then reached $4.1 million in 2012.